Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Carla Hundt
Safety and Efficacy From an 8 Week Double-Blind Trial and a 26 Week Open-Label Extension of Asenapine in Adolescents With Schizophrenia
Journal of Child and Adolescent Psychopharmacology
Mental Health
Child Health
Pharmacology
Perinatology
Psychiatry
Pediatrics
Related publications
Exploring the Long-Term Safety of Asenapine in Adults With Schizophrenia in a Double-Blind, Fixed-Dose, Extension Study
Neuropsychiatric Disease and Treatment
Efficacy and Safety of Liraglutide Versus Sitagliptin, Both in Combination With Metformin, in Chinese Patients With Type 2 Diabetes: A 26-Week, Open-Label, Randomized, Active Comparator Clinical Trial
Diabetes, Obesity and Metabolism
Internal Medicine
Endocrinology
Metabolism
Diabetes
Erratum To: Safety and Tolerability of Levomilnacipran ER in Major Depressive Disorder: Results From an Open-Label, 48-Week Extension Study
Clinical Drug Investigation
Medicine
Pharmacology
Efficacy and Safety of Repaglinide Added to Sitagliptin in Japanese Patients With Type 2 Diabetes: A Randomized 24-Week Open-Label Clinical Trial
Endocrine Journal
Endocrinology
Metabolism
Diabetes
An 8-Week Open Label Trial of L -Threonic Acid Magnesium Salt in Patients With Mild to Moderate Dementia
Personalized Medicine in Psychiatry
Long-Term Safety and Tolerability of Oral Tofacitinib in Patients With Crohn’s Disease: Results From a Phase 2, Open-Label, 48-Week Extension Study
Alimentary Pharmacology and Therapeutics
Hepatology
Pharmacology
Gastroenterology
Ziprasidone in Adolescents With Schizophrenia: Results From a Placebo-Controlled Efficacy and Long-Term Open-Extension Study
Journal of Child and Adolescent Psychopharmacology
Mental Health
Child Health
Pharmacology
Perinatology
Psychiatry
Pediatrics
Atomoxetine Improved Attention in Children and Adolescents With Attention-Deficit/Hyperactivity Disorder and Dyslexia in a 16 Week, Acute, Randomized, Double-Blind Trial
Journal of Child and Adolescent Psychopharmacology
Mental Health
Child Health
Pharmacology
Perinatology
Psychiatry
Pediatrics
Open-Label 24-Week Extension Study of Edaravone (MCI-186) in Amyotrophic Lateral Sclerosis
Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration
Medicine
Neurology
